Rapid innovations and upgradations in the healthcare and diagnostic technologies that allows for precise diagnostics in minimal time are positively influencing the demand within the global market.
The increase in the research and development activities intended for developing novel and accurate meningitis diagnosis solutions is also expected to bolster the demand dynamics within the global market over the forecast period of 2017 to 2025. However, lack of skilled technicians that can operate or handle advanced technological solutions and testing equipment may hamper the growth in the global market in coming years.
According to the corporate research report by the Transparency Market Research, the global meningitis diagnostic testing market is expected to expand at a steady growth rate of 3 % over the forecast period of 2017 to 2025.
The research report also predicts that the global market will surpass the evaluation of US$ 150.0 million by the end of the forecast period i.e. 2025. It also informs the readers that the global market was evaluated at US$ 105 million in the beginning of the forecast period i.e. 2016. Rising adoption of the solutions in the global market as well as easy availability of lateral flow assay are aiding in the expansion of the industry.
The increasing demand for point of care services is likely to drive growth within the global market in coming years. The point of care services offer more precise results in less time as compared to the conventional meningitis diagnostic testing methods. Furthermore, rising prevalence of meningitis is anticipated to drive the growth within the global market in near future. On the other hand, presence of complex and stringent regulatory framework may hamper the development of the global market in coming years.
The types of products offered by the players and manufacturers in the global market include lateral flow assay, ELISA tests, latex agglutination tests, PCR tests, and culture tests, among others. The PCR test segment amounted for the highest industry share in terms of revenue in the global market in 2016. The PCR testing solutions offer a higher sensitivity rate of almost 97 % and provide results faster than the traditional testing methods. Moreover, another segment anticipated to expand at a stellar rate in coming years within the global meningitis diagnostic testing market is lateral flow assay. This trend can be attributed to the low cost, reliable, and rapid nature of the lateral flow assay tests.
End users for the products and solutions offered by the players and manufacturers in the global market are diagnostic centers and hospitals, among others. Among these, the hospital segment accounted for the largest share within the global meningitis diagnostic testing industry in the year 2016. This trend can be attributed to the rising number of international hospitals that feature technologically superior laboratory infrastructure.
Major regions and leading nations in the global market include Europe (including Germany, Italy, the United Kingdom, France, Spain, and rest of the Europe), Latin America (including Mexico, Brazil, and rest of the Latin America), North America (including the United States and Canada), Middle East and Africa (including Sub Saharan Africa, Middle East and North Africa, and rest of the Middle East and Africa), and Asia Pacific (including Japan, Australia, India, New Zealand, China, and rest of the Asia Pacific). Among these, the North America region dominated the global market in 2016. The regional market with second largest share in the global market in 2016 was Asia Pacific.
Rising patient awareness as well as the easy availability of rapid diagnostic testing equipment and kits are some of the major contributors for the expansion of the global meningitis diagnostic testing market in North America region. On the other hand, Asia Pacific global market is set to expand at the highest growth rate over the forecast period owing to massive population base in some of the major nations in the region, such as India and China. Furthermore, increase in the patient awareness as well as developing laboratory infrastructure in the region is also expected to bolster the growth of Asia Pacific region in the global market in near future.
Few of the most notable players and manufacturers operational within the global market are Fast Track Diagnostics Ltd. (FTD), Bio-Rad Laboratories, Inc., BioFire Diagnostics, Luminex Corporation, Qnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Siemens Healthineers, IMMY, Nanosphere, Seegene Inc., and ELI Tech Group, among others. Major players and manufacturers in the global meningitis diagnostic testing market are focused on expanding their geographical presence as well as on diversifying their product portfolios by providing their conusmers with technologically advanced meningitis diagnostic testing solutions.
The research report also predicts that the global meningitis diagnostic testing market will expand at a stellar pace owing to the increasing demand for technologically superior meningitis diagnostic testing kits. This trend is anticipated to further intensify the competition within the global market. Players and manufacturers in the global market are engaged in corporate growth strategies such as strategic collaborations as well as acquisitions in order to capture a larger consumer base.
The global meningitis diagnostic testing market is segmented as follows:
Product |
|
End User |
|
Geography |
|
The market will surpass the evaluation of US$ 150.0 million by the end of 2025
The market is projected to register CAGR of over 3.0% from 2017 to 2025
The market is driven by increasing demand for point of care services and rising prevalence of meningitis
The PCR Assay segment is poised to account for leading share of the global market during the forecast period from 2017 to 2025
Key players in the global market include Fast Track Diagnostics Ltd. (FTD), Bio-Rad Laboratories, Inc., BioFire Diagnostics, Luminex Corporation, Qnostics, Abbott Laboratories
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Meningitis Diagnostic Testing Market Snapshot
4. Market Overview
4.1. Product Overview
4.2. Key Industry Events
4.3. Global Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, 2015-2025
4.4. Market Opportunity Map
4.5. Porter’s Analysis
4.6. Global Meningitis Diagnostic Testing Market Outlook
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Trends
5.1. Key Success factor for Top Players
5.2. Key Mergers and Acquisitions-In vitro Diagnostics (IVD) Industry
5.3. Regulatory Scenario
6. Global Meningitis Diagnostic Testing Market Analysis, by Product
6.1. Introduction
6.2. Key Findings
6.3. Global Meningitis Diagnostic Testing Market Value Share, by Product
6.4. Global Meningitis Diagnostic Testing Market Forecast, by Product
6.4.1. Latex Agglutination Tests
6.4.2. Lateral Flow Assay
6.4.3. PCR Assay
6.4.4. ELISA Tests
6.4.5. Culture Test
6.4.6. Others
6.5. Global Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product
7. Global Meningitis Diagnostics Testing Market Analysis, by End User
7.1. Introduction
7.2. Key Findings
7.3. Global Meningitis Diagnostic Testing Market Value Share Analysis, by End User
7.4. Global Meningitis Diagnostic Testing Market Forecast, by End User
7.4.1. Hospital
7.4.2. Diagnostic Center
7.4.3. Others
7.5. Global Meningitis Diagnostic Testing Market Attractiveness Analysis, by End User
8. Global Meningitis Diagnostic Testing Market Analysis, by Region
8.1. Global Market Scenario by Country
8.2. Global Meningitis Diagnostic Testing Market Value Share Analysis, by Region
8.3. Global Meningitis Diagnostic Testing Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4. Global Meningitis Diagnostic Testing Attractiveness Analysis By Region
9. North America Meningitis Diagnostic Testing Market Analysis
9.1. Key Findings
9.2. Market Overview
9.3. North America Meningitis Diagnostic Testing Market Value Share Analysis, by Country
9.4. North America Meningitis Diagnostic Testing Market Forecast, by Country
9.5. North America Meningitis Diagnostic Testing Market Value Share Analysis, by Product
9.6. North America Meningitis Diagnostic Testing Market Forecast, by Product
9.6.1. Latex Agglutination Tests
9.6.2. Lateral Flow Assay
9.6.3. PCR Assay
9.6.4. ELISA Tests
9.6.5. Culture Test
9.6.6. Others
9.7. North America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
9.8. North America Meningitis Diagnostic Testing Market Forecast, by End-user
9.8.1. Hospital
9.8.2. Diagnostic Center
9.8.3. Others
9.9. North America Meningitis Diagnostic Testing Market Attractiveness Analysis
10. Europe Meningitis Diagnostic Testing Market Analysis
10.1. Key Findings
10.2. Market Overview
10.3. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Country
10.4. Europe Meningitis Diagnostic Testing Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Product
10.6. Europe Meningitis Diagnostic Testing Market Forecast, by Product
10.6.1. Latex Agglutination Tests
10.6.2. Lateral Flow Assay
10.6.3. PCR Assay
10.6.4. ELISA Tests
10.6.5. Culture Test
10.6.6. Others
10.7. Europe Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
10.8. Europe Meningitis Diagnostic Testing Market Forecast, by End-user
10.8.1. Hospital
10.8.2. Diagnostic Center
10.8.3. Others
10.9. Europe Meningitis Diagnostic Testing Market Attractiveness Analysis
11. Asia Pacific Meningitis Diagnostic Testing Market Analysis
11.1. Key Findings
11.2. Market Overview
11.3. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Country
11.4. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by Country
11.4.1. U.K.
11.4.2. Germany
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest of Europe
11.5. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Product
11.6. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by Product
11.6.1. Latex Agglutination Tests
11.6.2. Lateral Flow Assay
11.6.3. PCR Assay
11.6.4. ELISA Tests
11.6.5. Culture Test
11.6.6. Others
11.7. Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
11.8. Asia Pacific Meningitis Diagnostic Testing Market Forecast, by End-user
11.8.1. Hospital
11.8.2. Diagnostic Center
11.8.3. Others
11.9. Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis
12. Latin America Meningitis Diagnostic Testing Market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Country
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Rest of Latin America
12.4. Latin America Meningitis Diagnostic Testing Market Forecast, by Country
12.5. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Product
12.6. Latin America Meningitis Diagnostic Testing Market Forecast, by Product
12.6.1. Latex Agglutination Tests
12.6.2. Lateral Flow Assay
12.6.3. PCR Assay
12.6.4. ELISA Tests
12.6.5. Culture Test
12.6.6. Others
12.7. Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
12.8. Latin America Meningitis Diagnostic Testing Market Forecast, by End-user
12.8.1. Hospital
12.8.2. Diagnostic Center
12.8.3. Others
12.9. Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis
13. Middle East & Africa Meningitis Diagnostic Testing Market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Country
13.3.1. Middle East & North Africa
13.3.2. Sub-Saharan Africa
13.3.3. Rest of Africa
13.4. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by Country
13.5. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Product
13.6. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by Product
13.6.1. Latex Agglutination Tests
13.6.2. Lateral Flow Assay
13.6.3. PCR Assay
13.6.4. ELISA Tests
13.6.5. Culture Test
13.6.6. Others
13.7. Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by End-user
13.8. Middle East & Africa Meningitis Diagnostic Testing Market Forecast, by End-user
13.8.1. Hospital
13.8.2. Diagnostic Center
13.8.3. Others
13.9. Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis
14. Competition Landscape
14.1. Meningitis Diagnostic Testing Market Share Analysis By Company, 2015
14.2. Competition Matrix
14.3. Company Profiles
14.3.1. Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers
14.3.1.1. Company Details
14.3.1.2. Business Overview
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Thermo Fisher Scientific, Inc.
14.3.2.1. Company Details
14.3.2.2. Business Overview
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.3. Abbott Laboratories.
14.3.3.1. Company Details
14.3.3.2. Business Overview
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.4. Bio-Rad Laboratories, Inc.
14.3.4.1. Company Details
14.3.4.2. Business Overview
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.5. Seegene Inc.
14.3.5.1. Company Details
14.3.5.2. Business Overview
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.6. DiagCor Bioscience Inc. Ltd
14.3.6.1. Company Details
14.3.6.2. Business Overview
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.7. BioFire Diagnostics (bioMerieux)
14.3.7.1. Company Details
14.3.7.2. Business Overview
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. IMMY
14.3.8.1. Company Details
14.3.8.2. Business Overview
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. Nanosphere (Luminex Corporation).
14.3.9.1. Company Details
14.3.9.2. Business Overview
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
List of Tables
TABLE 1 Global Meningitis Diagnostic Testing Market Value (US$ Mn) Forecast, by Product, 2015–2025
TABLE 2 Global Meningitis Diagnostic Testing Market Value (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 3 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
TABLE 4 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 5 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 6 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 7 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country /Sub-region, 2015–2025
TABLE 8 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 9 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 10 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 11 Table 11: Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 12 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 13 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 14 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 15 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 16 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 17 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by Product, 2015–2025
TABLE 18 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast, by End-user, 2015–2025
TABLE 19 Fast Track Diagnostics Ltd. (FTD) – Siemens Healthineers Business Overview
TABLE 20 Thermo Fisher Scientific, Inc. Business Overview
TABLE 21 Abbott Laboratories Business Overview
TABLE 22 Bio-Rad Laboratories, Inc. Business Overview
TABLE 23 Seegene Inc. Business Overview
TABLE 24 DiagCor Bioscience Inc. Ltd Business Overview
TABLE 25 BioFire Diagnostics (bioMérieux) Business Overview
TABLE 26 IMMY Business Overview
TABLE 27 Nanosphere (Luminex Corporation) Business Overview
List of Figures
FIG. 1 Global Meningitis Diagnostics Testing Market Share (US$ Mn), by Product, 2016
FIG. 2 Global Meningitis Diagnostics Testing Market Share (%), by End User, 2016
FIG. 3 Revenue Share, by product, 2016
FIG. 4 Revenue Share, by end user, 2016
FIG. 5 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
FIG. 6 Market Value Share, by Product (2016)
FIG. 7 Market Value Share, by Distribution Channel (2016)
FIG. 8 Market Value Share, by Region (2016)
FIG. 9 Global Meningitis Diagnostic Testing Market Value Share, by Product, 2016 and 2025
FIG. 10 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Latex Agglutination Test, 2015–2025
FIG. 11 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Lateral Flow Assay, 2015–2025
FIG. 12 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PCR Assay, 2015–2025
FIG. 13 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by ELISA Test, 2015–2025
FIG. 14 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Culture Test, 2015–2025
FIG. 15 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015–2025
FIG. 16 Global Meningitis Diagnostic Testing Market Attractiveness, by Product
FIG. 17 Global Meningitis Diagnostic Testing Market Value Share, by End-user, 2016 and 2025
FIG. 18 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
FIG. 19 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Centers, 2015–2025
FIG. 20 Global Meningitis Diagnostic Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other, 2015–2025
FIG. 21 Global Meningitis Diagnostic Testing Market Attractiveness, by End-user
FIG. 22 Global Meningitis Diagnostic Testing Market Value Share, by Region, 2016 and 2025
FIG. 23 Global Meningitis Diagnostic Testing Attractiveness Analysis, by Region, 2017–2025
FIG. 24 North America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG. 25 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country, 2017–2025
FIG. 26 North America Meningitis Diagnostic Testing Market Value Share Analysis, by Country, 2016 and 2025
FIG. 27 North America Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
FIG. 28 North America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
FIG. 29 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
FIG. 30 North America Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
FIG. 31 Europe Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG. 32 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
FIG. 33 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 34 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
FIG. 35 Europe Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
FIG. 36 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
FIG. 37 Europe Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
FIG. 38 Asia Pacific Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG. 39 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
FIG. 40 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 41 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
FIG. 42 Asia Pacific Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
FIG. 43 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
FIG. 44 Asia Pacific Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
FIG. 45 Latin America Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG. 46 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
FIG. 47 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 48 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
FIG. 49 Latin America Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
FIG. 50 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
FIG. 51 Latin America Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
FIG. 52 Middle East & Africa Meningitis Diagnostic Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
FIG. 53 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
FIG. 54 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 55 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by Product, 2016 and 2025
FIG. 56 Middle East & Africa Meningitis Diagnostic Testing Market Value Share Analysis, by End-user, 2016 and 2025
FIG. 57 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by Product, 2017–2025
FIG. 58 Middle East & Africa Meningitis Diagnostic Testing Market Attractiveness Analysis, by End-user, 2017–2025
FIG. 59 Thermo Fisher Scientific, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
FIG. 60 Thermo Fisher Scientific, Inc. Research & Development Expenses (US$ Mn), 2015–2016
FIG. 61 Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2016
FIG. 62 Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Business Segment, 2016
FIG. 63 Abbott Laboratories Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
FIG. 64 Abbott Laboratories Research & Development Expenses (US$ Bn), 2015–2016
FIG. 65 Abbott Laboratories Breakdown of Net Sales, by Region, 2016
FIG. 66 Abbott Laboratories Breakdown of Net Sales, by Segment, 2016
FIG. 67 Bio-Rad Laboratories, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
FIG. 68 Bio-Rad Laboratories, Inc. Research & Development Expenses (US$ Mn), 2015–2016
FIG. 69 Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Geography, 2016
FIG. 70 Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Segment, 2016
FIG. 71 Seegene Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
FIG. 72 Seegene Inc. Research & Development Expenses (US$ Mn), 2014–2016
FIG. 73 Seegene Inc. Breakdown of Net Sales, by Region, 2016
FIG. 74 Seegene Inc. Breakdown of Net Sales, by Business Segment, 2016
FIG. 75 Nanosphere Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
FIG. 76 Nanosphere Research & Development Expenses (US$ Mn), 2014–2016
FIG. 77 Nanosphere Breakdown of Net Sales, by Business Segment, 2016